We investigated the transactivation potential of the p.A119E-containing NKX2-5 haplotype and the p.A119S mutation using a functional assay developed in Saccharomyces cerevisiae that was used successfully in dissecting clinical relevance of mutations in CHD [6]–[8]. Here, NKX2-5 is linked to coronary artery disorder.